Live Breaking News & Updates on Zucker School Of Medicine

Stay updated with breaking news from Zucker school of medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)

Switching to UZEDY at four weeks after the last dose of once-monthly paliperidone palmitate provided the most comparable pharmacokinetic profile based on the relevant PK modeling data

Additional. ....

Nevada , United-states , Las-vegas , Christoph-correll , Eric-hughes , Invega-sustenna , Zucker-school-of-medicine , Teva-neuroscience-inc , Teva-pharmaceuticals , Teva-pharmaceutical-industries-ltd , Teva-at-psych-congress-elevate , Mental-health-services-administration

Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia

Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

France , United-states , Christophe-douat , Medincell-euronext , Christoph-correll , Eric-hughes , Teva-pharmaceuticals , Teva-pharmaceutical-industries-ltd , Euronext , Zucker-school-of-medicine , Medincell-announce-positive-phase , Once-monthly-subcutaneous-long-acting-injectable

Phase 3 SOLARIS Trial Demonstrates Potential of TEV-'749 in Schizophrenia

Phase 3 SOLARIS Trial Demonstrates Potential of TEV-'749 in Schizophrenia
psychiatrictimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychiatrictimes.com Daily Mail and Mail on Sunday newspapers.

Christophe-douat , Christoph-correll , Eric-hughes , Zucker-school-of-medicine , Drug-administration , Teva-pharmaceuticals , Negative-syndrome-scale , Clinical-global-impressions , Social-performance-scale , Zucker-school ,

Long-Acting Subcutaneous Olanzapine Effective in Schizophrenia Trial

Long-Acting Subcutaneous Olanzapine Effective in Schizophrenia Trial
empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.

Christoph-correll , Zucker-school-of-medicine , Negative-syndrome-scale , Clinical-global-impressions , Social-performance , Zucker-school ,

Study Suggests COVID Boosters Provide No Added Protection for Kids

Study Suggests COVID Boosters Provide No Added Protection for Kids
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

Philadelphia , Pennsylvania , United-states , Boston , Massachusetts , Peter-marks , Paul-offit , Hank-bernstein , Kena-swanson , Products-advisory-committee , Pfizer , Drug-administration